Public Notice
Public Notice: Secondary Statistical Re-Analysis of Legacy Clinical Trial Data
Date of Notice: November 4, 2026
Data Controller: Lutetia Therapeutics Inc.
1. Purpose and Overview
Lutetia Therapeutics Inc. ("Lutetia"), as the designated Data Controller, is conducting a secondary biostatistical re-analysis of pseudonymized, legacy clinical trial datasets from the Phase 3 PLEO, PREMIER, and Open-Label Extension (OLE) clinical trials involving PXT3003.
The primary objective of this secondary analysis is to refine clinical development endpoints, model regulatory rescue pathways, evaluate long-term functional stability, and prepare documentation for submissions to regulatory authorities (including the U.S. Food and Drug Administration - FDA).
2. Legal Basis and Regulatory Alignment
EU GDPR & French Public Health Code: This secondary re-analysis aligns strictly with the original scientific and regulatory research purposes (finalité) for which the data were collected, in accordance with applicable EU General Data Protection Regulation (GDPR) standards and French national health data regulations (CNIL reference methodologies).
Scope of Processing: The activity involves data-only statistical re-analysis. No new patient recruitment or biological sample re-testing is involved.
3. Data Hosting & International Transfers
Location of Processing: The underlying pseudonymized datasets are hosted on secure, compliant servers in the United States by authorized biostatistical clinical research organizations (CROs), including Pentara Corporation.
Protections: All transfers and processing operations are governed by formal Data Transfer Agreements (DTAs) and Standard Contractual Clauses (SCCs) to ensure strict continuity of data protection and privacy standards.
4. Patient Privacy & Data Subject Rights
All data processed during this re-analysis remain fully pseudonymized. Individual patient identities are not accessible by Lutetia or its processing partners. Data subjects maintain all rights provided under applicable data protection laws.
For any inquiries regarding data protection compliance or privacy rights, please contact our Data Protection Officer at:
privacy@lutetiatherapeutics.com / p.leguellec@yeched-mat.com
